Patient‐Reported Symptom Control of Diarrhea and Flushing in Patients With Neuroendocrine Tumors Treated With Lanreotide Depot/Autogel: Results From a Randomized, Placebo‐Controlled, Double‐Blind and 32‐Week Open‐Label Study
Oncologist - United States
doi 10.1634/theoncologist.2017-0284
Full Text
Open PDFAbstract
Available in full text
Date
October 16, 2017
Authors
Publisher
Alphamed Press